Alaunos Therapeutics, Inc. Increase (Decrease) in Deferred Liabilities
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Deferred Liabilities of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2021-03-01
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2019-12-31 was -$17.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2019-09-30 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2019-06-30 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2019-03-31 was $17.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2019 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was -$125.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was -$139.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was -$380.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$17.00K derived: sum of 2 quarters · filed 2020-11-05 | -$17.00K derived: sum of 3 quarters · filed 2020-11-05 | $0.00 10-K · filed 2020-03-02 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $17.00K 10-Q · filed 2020-11-05 | $4.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $17.00K 10-Q · filed 2020-08-06 | $4.00K derived: sum of 3 quarters · filed 2021-03-01 | -$34.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $17.00K 10-Q · filed 2020-05-07 | $4.00K derived: sum of 2 quarters · filed 2021-03-01 | -$34.00K derived: sum of 3 quarters · filed 2021-03-01 | -$71.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$51.00K derived: sum of 2 quarters · filed 2021-03-01 | -$88.00K derived: sum of 3 quarters · filed 2021-03-01 | -$125.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$75.00K derived: sum of 2 quarters · filed 2019-11-07 | -$112.00K 10-Q · filed 2019-11-07 | -$149.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$74.00K 10-Q · filed 2019-08-08 | -$111.00K derived: sum of 3 quarters · filed 2020-03-02 | -$148.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$37.00K 10-Q · filed 2019-05-08 | -$74.00K derived: sum of 2 quarters · filed 2020-03-02 | -$111.00K derived: sum of 3 quarters · filed 2020-03-02 | -$145.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$74.00K derived: sum of 2 quarters · filed 2020-03-02 | -$108.00K derived: sum of 3 quarters · filed 2020-03-02 | -$139.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$71.00K derived: sum of 2 quarters · filed 2018-11-09 | -$102.00K 10-Q · filed 2018-11-09 | -$160.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$65.00K 10-Q · filed 2018-08-08 | -$123.00K derived: sum of 3 quarters · filed 2019-03-05 | -$206.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-03-31 | -$31.00K 10-Q · filed 2018-05-10 | -$89.00K derived: sum of 2 quarters · filed 2019-03-05 | -$172.00K derived: sum of 3 quarters · filed 2019-03-05 | -$320.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2016-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | -$141.00K derived: sum of 2 quarters · filed 2019-03-05 | -$289.00K derived: sum of 3 quarters · filed 2019-03-05 | -$380.00K 10-K · filed 2019-03-05 |
| 2016-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$231.00K derived: sum of 2 quarters · filed 2017-11-06 | -$322.00K 10-Q · filed 2017-11-06 | -$442.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$239.00K 10-Q · filed 2017-07-31 | -$359.00K derived: sum of 3 quarters · filed 2018-03-01 | -$447.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$91.00K 10-Q · filed 2017-05-01 | -$211.00K derived: sum of 2 quarters · filed 2018-03-01 | -$299.00K derived: sum of 3 quarters · filed 2018-03-01 | -$388.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$208.00K derived: sum of 2 quarters · filed 2018-03-01 | -$297.00K derived: sum of 3 quarters · filed 2018-03-01 | -$189.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$177.00K derived: sum of 2 quarters · filed 2016-11-09 | -$69.00K 10-Q · filed 2016-11-09 | -$128.00K derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $19.00K 10-Q · filed 2016-08-09 | -$40.00K derived: sum of 3 quarters · filed 2017-02-16 | |
| 2015-03-31 | $108.00K 10-Q · filed 2016-05-10 | $49.00K derived: sum of 2 quarters · filed 2017-02-16 | ||
| 2014-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$213.00K 10-K · filed 2017-02-16 | ||
| 2014-09-30 | -$154.00K 10-Q · filed 2015-11-02 | |||
| 2013-12-31 | $625.00K 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |